RSS
|
Login
|
Register
Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Issue Archive
Events
Awards
Webcasts
Surveys
Directories
PMD
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
Home
>
New Drug Dossier
> Liquadd
Liquadd
April 07 2008
Liquadd is a new formulation of dextroamphetamine, one of the most frequently prescribed molecules for the treatment of ADHD.
Login Required
Please login to receive access to this portion of mmm-online.com.
Email address:
Password:
Forgot password?
Keep me signed in
Already a paid subscriber?
If you are a MMM Drug Dossier subscriber, your login information should have been e-mailed to you. If you are unable to login or need to update your email address, please contact MMM customer service at
mmmsubs@haymarketmedia.com
or (646) 638-6048.
Not yet a subscriber? You must have a Drug Dossier subscription in order to access this portion of mmm-online.com,
click here to subscribe
.
Most Popular
Pfizer's Saxton: healthcare professionals must lead CME
MM&M Awards 2008--and the finalists are:
J&J weighs pruning its agencies
Massachusetts dumps gift ban, punts on data
GSK downsizes in consumer healthcare consolidation
MM&M Awards finalists unveiled next week
MM&M Awards 2008 Finalists
AstraZeneca says docs top driver to patient assistance programs
Location and size a determinant in physician access: study
MM&M Awards 2008: The finalists are in
Most Emailed
Pfizer sacks commercial support of CME
PhRMA Code cracks down on gifts to docs
Location and size a determinant in physician access: study
J&J weighs pruning its agencies
Fed up Sermo docs draft manifesto
Pfizer's Saxton: healthcare professionals must lead CME
More docs using mobile devices: Manhattan Research
MM&M Awards 2008--and the finalists are:
AstraZeneca says docs top driver to patient assistance programs
Rx drug word-of-mouth occurs largely offline: study
Most Recent
Waxman: Part D brought pharmas $3.7 billion "windfall"
MM&M Awards 2008: The finalists are in
Nielsen and Wolters Kluwer Health form alliance
AstraZeneca says docs top driver to patient assistance programs
J&J weighs pruning its agencies
MM&M Awards 2008--and the finalists are:
MM&M Awards 2008 Finalists
Location and size a determinant in physician access: study
Teva in $7.4 billion Barr buy
GSK downsizes in consumer healthcare consolidation
Popular Tags
Account wins & losses
Advertising
Agency
Approval
Awards
Biotech
Business
Consumer
Continuing medical education (CME)
Digital
Direct to consumer (DTC)
Direct to patient (DTP)
FDA
Generic
Government
Legal
Marketing & Communications
Marketing Research
Media
Online
Pharmaceutical
Professional
Promotion
Regulatory
Sales force
Home
|
News
|
Features
|
Events
|
Surveys
|
Lists
|
Directories
|
Jobs
|
About Us
|
Contact Us
|
Subscribe
|
Newsletters
|
PMD
|
Advertise
|
Editorial Advisory Board
|
RSS